Acumen starts coverage of Auxly Cannabis Group stock at CAD 5.00

Published on 10/15/2026 at 13:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Auxly posted CAD 45.80 million revenue in the second quarter of 2026. Auxly Cannabis Group stock costs EUR 2.07 on October 15, 2026.

Coverage and operating metrics

Acumen Capital began coverage with a CAD 5.00 target on October 2, 2026.
Auxly reported CAD 45.80 million in revenue for the second quarter of 2026.
Auxly Cannabis Group stock was trading at EUR 2.07 at 1:07 p.m. CEST at Lang & Schwarz on October 15, 2026.

XLY, CA05335P7039, Illustration mit AI erstellt.

Acumen Capital began coverage of Auxly Cannabis Group with a CAD 5.00 price target on October 2, 2026, according to IT Boltwise. The report also cited a Buy recommendation, making the new target the clearest recent valuation signal for Auxly stock.

What does the second quarter show?

Auxly generated CAD 45.80 million in revenue in the second quarter of 2026, according to the company's investor materials as summarized by IT Boltwise. Net income reached CAD 7.70 million, although the same report said CAD 6.50 million came from a one-time item, leaving recurring profitability as the central question for the next report.

Structured quarterly figures for the period ended June 30, 2026 show revenue of CAD 45.80 million and net income of CAD 7.70 million. Revenue was CAD 39.75 million in the first quarter of 2026, so second-quarter revenue increased by CAD 6.05 million, or 15.22 percent, sequentially. Operating income was negative CAD 3.91 million in the second quarter after negative CAD 5.06 million in the first quarter.

Three dates reshape the story

On July 22, 2026, Auxly announced a 14-for-1 share consolidation. On July 28, 2026, trading began on the post-consolidation basis. On August 13, 2026, Auxly reported second-quarter results, including CAD 45.80 million in revenue. These dated milestones are listed on Auxly's investor page.

Which dates come next?

Auxly's next quarterly results are scheduled for November 16, 2026, according to Investing.com. The date will give investors a fresh test of whether the second-quarter profit included enough recurring operating strength.

Stock value and operating risk

On October 2, 2026, the TSX quote cited in the coverage report stood at CAD 3.43, while the reported 52-week range was CAD 1.54 to CAD 3.75. The same report placed market capitalization at CAD 347.5 million. That range shows why the CAD 5.00 target depends on execution rather than revenue growth alone.

Auxly's investor page identifies the company as a cannabis consumer packaged-goods business and confirms its TSX listing under XLY. Its product portfolio includes branded cannabis products across dried formats, pre-rolls, vaporizers and other processed categories. The combination of revenue growth and one-time profit contribution leaves the November report as the next material test.

Price remains the daily anchor

Auxly Cannabis Group stock was trading at EUR 2.07 at Lang & Schwarz on October 15, 2026 at 1:07 p.m. CEST. The quote is shown as an intraday indication in euros; no Xetra closing comparison is stated here.

The further course of trading is shown by the continuously updated real-time quote of Auxly Cannabis Group stock.